Kaynakça
Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. Department of Human and Health Services;2017. Last accessed date: 01 May 2018. Available from: https://aidsinfo.nih.gov/contentfiles/ lvguidelines/adultandadolescentgl.pdf
European AIDS Clinical Society Guidelines Version 8.1. 2016. Last accessed date: 02 May 2018. Available from: http://www.eacsociety.org/files/ guidelines_8.1-english.pdf
Molas E, Luque S, Retamero A, Echeverría-Esnal D, Guelar A, Montero M, Guerri R, Sorli L, Lerma E, Villar J, Knobel H. Frequency and Severity of Potential Drug Interactions in A Cohort of HIV-infected Patients Identified Through a Multidisciplinary Team. HIV Clin Trials. 2018;19:1-7.
Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. Department of Human and Health Services;2014. Last accessed date: 01 May 2018. Available from: https://aidsinfo.nih.gov/contentfiles/ AdultandAdolescentGL003390.pdf
European AIDS Clinical Society Guidelines Version 7.1. 2014. Last accessed date: 02 May 2018. Available from: http://www.eacsociety.org/files/ guidelines_english_71_141204.pdf
INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373:795-807.
TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan- Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N"Dri-Yoman T, Salamon R, Eholié SP, Anglaret X. A Trial of Early Antiretroviral and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015;373:808-22.
Iniesta-Navalón C, Franco-Miguel JJ, Gascón-Cánovas JJ, Rentero-Redondo L. Identification of Potential Clinically Significant Drug Interactions in HIV-infected Patients: A Comprehensive Therapeutic Approach. HIV Med. 2015;16:273-9.
Wassner C, Maiti S, Kodroff K, Cohen H. Iatrogenic Adrenal Insufficiency Secondary to Combination Therapy with Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Interlaminar Triamcinolone Injection in an AIDS Patient. J INT Assoc Provid AIDS Care. 2017;16:535-9.
